home / stock / ara / ara news


ARA News and Press, American Renal Associates Holdings Inc From 09/12/19

Stock Information

Company Name: American Renal Associates Holdings Inc
Stock Symbol: ARA
Market: NYSE
Website: americanrenal.com

Menu

ARA ARA Quote ARA Short ARA News ARA Articles ARA Message Board
Get ARA Alerts

News, Short Squeeze, Breakout and More Instantly...

ARA - Midday Gainers / Losers

Gainers:  Sintx Technologies (NASDAQ: SINT ) +71% . Ruhnn Holding Limited (NASDAQ: RUHN ) +29% . Jaguar Health (NASDAQ: JAGX ) +19% . T2 Biosystems (NASDAQ: TTOO ) +15% . OncoCyte Corporation (NYSEMKT: OCX ) +13% . Libbey (NYSEMKT: LBY ) +13% . Cyclerion Therapeutics (NASDAQ: CY...

ARA - ADPT, CLDR, GIII, LVGO and MDP among midday movers

Gainers:  Edesa Biotech (NASDAQ: EDSA ) +88% . G-III Apparel Group (NASDAQ: GIII ) +26% . Signet Jewelers (NYSE: SIG ) +22% . Pareteum Corporation (NASDAQ: TEUM ) +20% . Vista Oil & Gas S.A.B. de C.V. (NYSE: VIST ) +18% . Forward Industries (NASDAQ: FORD ) +17% . Lands' End ...

ARA - American Renal completes restatement of financials; shares ahead 4%

American Renal Associates ( ARA +4.4% ) announces that it has filed its restated financial statements to the SEC for fiscal year 2018 and Q1 and Q2 2019. More news on: American Renal Associates Holdings, Inc., Healthcare stocks news, Stocks on the move, Read more ...

ARA - American Renal Associates Holdings, Inc. Completes Restatement of Prior Financial Statements

Files Form 10-K for the Fiscal Year Ended December 31, 2018 and Form 10-Q for the Fiscal Quarters Ended March 31, 2019 and June 30, 2019 Provides 2019 Outlook and Preliminary 2020 Outlook American Renal Associates Holdings, Inc. (“ARA” or the “Company”)...

ARA - Bragar Eagel & Squire is Investigating Certain Officers and Directors of Lannett, Molson Coors, AxoGen, and American Renal Associates and Encourages Investors to Contact the Firm

NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire is investigating certain officers and directors of Lannett Company, Inc. (NYSE: LCI), Molson Coors Brewing Company (NYSE: TAP), AxoGen, Inc. (NASDAQ: AXGN), and American Renal Associates Holdings, Inc. (NYSE: ARA) on beha...

ARA - NYSE: ARA Investor Notice: Lawsuit against American Renal Associates Holdings, Inc. announced by Shareholders Foundation

SAN DIEGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in American Renal Associates Holdings, Inc. (NYSE: ARA) shares. Investors, who purchased shares of American Renal Associates Holdings, Inc. (NYSE: ARA),...

ARA - American Renal Associates Holdings, Inc. Applauds the Advancing American Kidney Health Initiative

American Renal Associates Holdings, Inc. (“ARA” or the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, issued the following statement regarding the July 10, 2019, Executive Order by President Trump related to ...

ARA - Trump to reboot U.S. kidney care via executive order

President Trump is scheduled to sign an executive order this morning aimed at shaking up U.S. care for kidney disease, including new incentives to shift dialysis from clinics to the home. Key points : More news on: DaVita Inc., Fresenius Medical Care AG & Co. KGaA, American Renal Asso...

ARA - Dialysis firms under early pressure on Trump plan to shake up kidney care market

Dialysis services providers DaVita (NYSE: DVA ) and Fresenius Medical Care (NYSE: FMS ) are down  1%  and  3% , respectively, premarket (both on light volume) on the heels of a report from Politico that the Trump administration is planning to announce initiatives aimed at en...

ARA - ARA & NTNX- Deadline Alert - Bronstein, Gewirtz & Grossman, LLC

NEW YORK, NY / ACCESSWIRE / May 28, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronst...

Previous 10 Next 10